Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Archos, Bayer, Bureau Veritas, Merck: European Equity Preview

The following companies’ shares may have unusual moves in European trading. Stock symbols are in parentheses.

The Stoxx Europe 600 Index fell 4.1 percent to 228.98. The Stoxx 50 Index dropped 3.6 percent to 2,199.01. The Euro Stoxx 50 Index, a benchmark measure for nations using the euro, decreased 3.7 percent to 2,286.91.

Archos SA (JXR FP): The maker of tablet computers posted a first-half profit of 1.7 million euros ($2.4 million). The shares fell 8.8 percent to 7.27 euros.

Bayer AG (BAYN GY) and Merck KGaA (MRK GY): German pharmaceutical companies must grant more than 2 billion euros in discounts on prescription drugs this year, Handelsblatt reported, citing a study from research firm IMS Health. Bayer’s shares dropped 4.1 percent to 46.73 euros, while Merck’s shares lost 4.2 percent to 64.80 euros.

Bureau Veritas SA (BVI FP): The consulting-services provider said it acquired Civil-Aid Technoclinic Pty, an Indian provider of evaluation services for public and industrial infrastructure. The shares fell 3.9 percent to 51.59 euros.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.